X4 Pharmaceuticals, Inc. · NASDAQ:XFOR
Craig Adam R bought 4,600 X4 Pharmaceuticals, Inc. shares (Form 4)
Traded Oct 16, 2026 · Filed Oct 19, 2026
On Oct 16, 2026, Craig Adam R (Director, Executive Chairman) bought 4,600 X4 Pharmaceuticals, Inc. shares at US$2.58 for US$11,884, leaving 333,251 shares. Filed Oct 19, 2026 (Form 4).
- Bought
- 4,600 shares
- Price
- US$2.58
- Value
- US$11,884
- Holding after
- 333,251 shares
- Trading plan
- No
- Role
- Director, Executive Chairman
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Oct 16, 2026 | Common Stock | Buy | 4,600 | US$2.58 | 333,251 | Direct |
Source
Download original · View original at SEC
Related
- X4 Pharmaceuticals, Inc.
- Craig Adam R
- X4 Pharmaceuticals, Inc. shareholders
- Form 4 · Craig Adam R · Aug 13, 2026
- Schedule 13G/A · FMR LLC · Oct 7, 2026
- Form 4 · Kirske David · Oct 5, 2026
- Schedule 13G · Venrock Healthcare Capital Partners III, L.P. · Sep 21, 2026
- Schedule 13G/A · Deep Track Capital, LP · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026